Harry Thomasian Jr. - 31 Jul 2026 Form 4 Insider Report for PRECIGEN, INC. (PGEN)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
31 Jul 2026, 16:26:18 UTC
Prior SEC filing
01 Jul 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Harry Thomasian, Jr., by Donald P. Lehr, as attorney-in-fact

Key filing fact

Harry Thomasian Jr. filed Form 4 for PRECIGEN, INC. (PGEN) on 31 Jul 2026.

Key facts

  • This page summarizes Harry Thomasian Jr.'s Form 4 filing for PRECIGEN, INC. (PGEN).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 31 Jul 2026, 16:26.

Change

  • Previous filing in this sequence was filed on 01 Jul 2026.
  • Current net transaction value: -$606,000.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001886301 Primary reporting owner

Thomasian Harry Jr.

Relationship
Chief Financial Officer
Address
20374 SENECA MEADOWS PARKWAY, GERMANTOWN
Signature
/s/ Harry Thomasian, Jr., by Donald P. Lehr, as attorney-in-fact
Signature date
31 Jul 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

PGEN transaction

Common Stock

Sale

Transaction value
$606,000
Shares
-100,000
Change %
-28%
Price
$6.06
Shares after
254,535
Date
31 Jul 2026
Ownership
Direct
Footnotes
F1, F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 2 footnotes

Footnote F1

Represents shares sold pursuant to the terms of a 10b5-1 plan adopted by the reporting person.

Footnote F2

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.00 to $6.15, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .